Immunai
Mapping the Immune System with AI to Improve Health
174 employees · est. 2019 · New York, United States
Parallel Bio
Using the immune system to cure disease.
27 employees · est. 2021 · Watertown, United States
Immunai is the older company (2019 vs 2021); Immunai is the larger of the two.
Side-by-Side Comparison
| Metric | Immunai | Parallel Bio |
|---|---|---|
| Founded | ||
| Founded | 2019 older | 2021 |
| Headquarters | ||
| Headquarters | New York, United States | Watertown, United States |
| Employees | ||
| Employees | 174 larger | 27 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $300.50M | $25.43M |
| Funding Rounds | ||
| Funding Rounds | 5 | 4 |
| Services | ||
| Services | Target Discovery, Preclinical Evaluation, Clinical Trial Optimization, Data Generation, Data Augmentation, Compute and Validate Therapeutic Insights, Recommendation Engine | Human-first Drug Discovery, Precision Medicine Solutions, Foundation Model Development, Biological Atlas Creation |
| Target Customers | ||
| Target Customers | biopharmaceutical companies, research institutions, pharma companies | Pharmaceutical Companies, Biotech Firms, Research Institutions, Healthcare Providers |
| Taxonomy | ||
| Taxonomy | Immune System Mapping, Single-cell Genomics, Biotech, Therapeutic Discoveries, Drug Development, Patient Outcomes, Biomarker Discovery, High-resolution Profiling, Immune Profiling, Cellular Response Analysis, Cancer Research, Genomic Technologies, High-dimensional Statistics, Single-cell Biology | Immune System Organoids, Drug Discovery, Immunotherapy Development, Computational Biology, Biotechnology Innovation, Human Health Insights, Disease Modeling, Organoid Technology, Therapeutic Discovery, Immune System Research, Personalized Medicine, Clinical Insights, Health Technology, Precision Medicine |
| Website | ||
| Website | immunai.com | parallel.bio |
About Immunai
Immunai, founded in 2019, is a United States-based startup that is revolutionizing the Biotechnology and Pharmaceutical industries with its innovative approach. The company's slogan, "Mapping the Immune System with AI to Improve Health," reflects its mission to map and decode the immune system using...
About Parallel Bio
Parallel Bio is a promising startup founded in 2021, aiming to revolutionize the field of drug discovery with its innovative technology. The company has developed a groundbreaking platform described as a human 'immune system in a dish', which holds the potential to significantly improve the efficien...
We will tell you when either one moves
BounceWatch watches Immunai and Parallel Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Immunai and Parallel Bio — by email.
Frequently Asked Questions
Compare Immunai with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Immunai on 3 Aug 2026, and Parallel Bio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.